SCHEMBL611252

SCHEMBL611252

CC1(C)CCCC1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7998791 0.92
SCHEMBL601382 0.78
SCHEMBL20880466 0.72
SCHEMBL16934002 0.72
SCHEMBL9820428 0.72
Ammonia Solution, Strong SCHEMBL6551899 0.71
Ammonia Solution, Strong SCHEMBL11046587 0.71 ENTPD5 (0.32)
SCHEMBL25973610 0.69 CYP3A4 (0.34)
SCHEMBL13006648 0.67
SCHEMBL18030014 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180008523-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD DEVICEFARM INC (US) 2018-01-11 US claimed
US-20180000937-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD DEVICEFARM INC (US) 2018-01-04 US claimed
US-20170361078-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD NATIONAL SCIENCE FOUNDATION 2017-12-21 US claimed
US-20170354616-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD NATIONAL SCIENCE FOUNDATION 2017-12-14 US claimed
US-20170354815-A1 ONYCHOMYCOSIS TREATMENT SYSTEM AND METHOD NATIONAL SCIENCE FOUNDATION 2017-12-14 US claimed
EP-2044192-A2 ENHANCED OXYGEN CELL CULTURE PLATFORMS University of Miami (US) 2009-04-08 EP claimed
WO-2008006104-A2 ENHANCED OXYGEN CELL CULTURE PLATFORMS UNIVERSITY OF MIAMI (US) 2008-01-10 WO claimed
US-20080009027-A1 Enhanced Oxygen Cell Culture Platforms UNIVERSITY OF MIAMI (US) 2008-01-10 US claimed
US-7081092-B2 Methods and apparatus for monitoring and quantifying the movement of fluid IMCOR PHARMACEUTICAL COMPANY (US) 2006-07-25 US claimed
US-20050049484-A1 Methods and apparatus for monitoring and quantifying the movement of fluid TARGESON, INC. 2005-03-03 US claimed
US-6802813-B2 Methods and apparatus for monitoring and quantifying the movement of fluid IMCOR PHARMACEUTICAL CO. 2004-10-12 US claimed
US-20030220563-A1 Methods and apparatus for monitoring and quantifying the movement of fluid TARGESON, INC. 2003-11-27 US claimed
US-20020065467-A1 Methods and apparatus for monitoring and quantifying the movement of fluid SCHUTT ERNEST G (US) 2002-05-30 US claimed
WO-1998053855-A1 METHODS AND APPARATUS FOR MONITORING AND QUANTIFYING THE MOVEMENT OF FLUID ALLIANCE PHARMACEUTICAL CORP. (US) 1998-12-03 WO claimed
US-20240024229-A1 COMPOSITIONS, METHODS &amp; SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS PEARL THERAPEUTICS, INC. 2024-01-25 US disclosed
US-20230340506-A1 Microorganisms and methods for producing cannabinoids and cannabinoid derivatives THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-26 US disclosed
CN-115942959-A Pharmaceutical composition for improving respiratory system injury and application of pharmaceutical composition for improving respiratory system injury 洪铭谦 2023-04-07 CN disclosed
US-5876696-A Composition comprising a fluorine containing surfactant and perfluoropentane for ultrasound SONUS PHARMACEUTICALS, INC. (US) 1999-03-02 US disclosed
WO-1998053855-A1 METHODS AND APPARATUS FOR MONITORING AND QUANTIFYING THE MOVEMENT OF FLUID ALLIANCE PHARMACEUTICAL CORP. (US) 1998-12-03 WO disclosed
US-5558853-A WATER IMMISCIBLE FLUORINE COMPOUND SONUS PHARMACEUTICALS (US) 1996-09-24 US disclosed